GO:0060939 epicardium-derived cardiac fibroblast cell development: Developmental Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060939 describes the developmental progression of epicardium-derived cardiac fibroblasts from their formation to mature extracellular matrix-secreting cells [1, 2].
• Epicardium-derived cells (EPDCs) undergo epithelial-to-mesenchymal transition (EMT) and migrate into the myocardium to give rise to cardiac fibroblasts, smooth muscle cells, and endothelial cells [2, 4].
• Key transcription factors such as WT1, TCF21, and BNC1 regulate the specification and heterogeneity of epicardium-derived fibroblasts [6, 7].
• Disruption of epicardium-derived fibroblast development is linked to impaired cardiac repair, fibrosis, and congenital heart defects [1, 5, 8].
• Research models include lineage tracing, conditional knockout mice, and human pluripotent stem cell-derived epicardium [7, 8].
• CRISPR-based knockout, knock-in, and overexpression models enable causal interrogation of genes driving epicardium-derived cardiac fibroblast development [1, 8].
Description
Epicardium-derived cardiac fibroblast cell development (GO:0060939) is the biological process by which epicardial cells give rise to mature cardiac fibroblasts, connective tissue cells that secrete a collagen-rich extracellular matrix in the heart [1, 2]. This process is essential for normal heart development, as epicardium-derived cells (EPDCs) migrate into the myocardium and differentiate into fibroblasts that provide structural support and participate in signaling [2, 4]. Understanding GO:0060939 is critical for researchers studying cardiac fibrosis, regeneration, and congenital heart disease, because perturbations in this developmental program can lead to pathological remodeling or defective heart formation [1, 5, 8]. The term encompasses the entire trajectory from epicardial cell formation through EMT, migration, and maturation into matrix-secreting fibroblasts [3, 4].
epicardium-derived cardiac fibroblast cell development At A Glance
| GO ID | GO:0060939 |
|---|---|
| GO term | epicardium-derived cardiac fibroblast cell development |
| Ontology | biological_process |
| Synonym | None |
| Major function | Development of collagen-secreting cardiac fibroblasts from epicardial progenitors |
| Related cell type | Epicardium-derived cardiac fibroblast |
| Key developmental event | Epithelial-to-mesenchymal transition (EMT) and migration into myocardium |
| Associated genes | WT1, TCF21, BNC1, TBX18, SNAI1, etc. |
| Disease relevance | Cardiac fibrosis, congenital heart defects, impaired regeneration |
What Is GO:0060939?
GO:0060939 is defined as the process whose specific outcome is the progression of an epicardial-derived cardiac fibroblast over time, from its formation to the mature state. An epicardial-derived cardiac fibroblast is a connective tissue cell of the heart that arises from the epicardium and secretes an extracellular matrix rich in collagen and other macromolecules [1, 2].
Why Is epicardium-derived cardiac fibroblast cell development Important in Cell Biology?
GO:0060939 is important because epicardium-derived cardiac fibroblasts are the primary source of extracellular matrix in the developing and injured heart, and their proper development is required for myocardial compaction, coronary vessel formation, and cardiac repair [1, 2, 8]. Dysregulation of this process contributes to fibrosis, heart failure, and congenital anomalies, making it a key area for regenerative medicine and drug discovery [5, 6].
• Provides structural integrity to the heart through collagen and matrix secretion.
• Supports coronary vessel development via paracrine signaling [2, 4].
• Critical for embryonic heart development and myocardial compaction.
• Dysregulation leads to cardiac fibrosis after injury [1, 8].
• Involved in congenital heart defects such as ventricular septal defects.
• Source of fibroblasts in adult heart repair and regeneration.
• WT1 expression marks epicardial progenitors and is essential for fibroblast development.
• BNC1 regulates heterogeneity in human pluripotent stem cell-derived epicardium.
• Target for anti-fibrotic therapies and cardiac regeneration strategies [1, 8].
• Enables lineage tracing and CRISPR screens to identify causal genes [7, 8].
What Happens During epicardium-derived cardiac fibroblast cell development?
Epicardial cell formation and EMT
In simple terms: Epicardial cells first form a layer around the heart and then change into migratory cells.
The epicardium, a mesothelial layer covering the heart, is derived from the proepicardial organ. Epicardial cells undergo epithelial-to-mesenchymal transition (EMT), a process regulated by transcription factors such as WT1 and SNAI1, allowing them to delaminate and migrate into the myocardium [2, 4, 6].
Migration and differentiation into fibroblasts
In simple terms: These migratory cells move into the heart muscle and become fibroblasts.
After EMT, epicardium-derived cells (EPDCs) invade the myocardium and differentiate into cardiac fibroblasts, smooth muscle cells, and endothelial cells. This differentiation is controlled by TCF21, BNC1, and other transcriptional regulators that specify the fibroblast lineage [1, 7].
Maturation and extracellular matrix secretion
In simple terms: The new fibroblasts mature and start producing the matrix that supports heart tissue.
Mature epicardium-derived cardiac fibroblasts secrete an extracellular matrix rich in collagen and other macromolecules, providing structural support and signaling cues. This maturation step is essential for myocardial compaction and coronary vessel stabilization [1, 3, 8].
Crosstalk with myocardium and coronary vessels
In simple terms: Fibroblasts communicate with heart muscle and blood vessels to coordinate growth.
Epicardium-derived fibroblasts participate in bidirectional signaling with cardiomyocytes and coronary endothelial cells, influencing proliferation, survival, and vessel formation. This crosstalk is mediated by growth factors and cytokines, and its disruption leads to developmental defects [3, 5, 8].
Key Genes Involved in GO:0060939 epicardium-derived cardiac fibroblast cell development
The following genes are experimentally implicated in the development of epicardium-derived cardiac fibroblasts.
| Gene | Major Role | Research Relevance |
|---|---|---|
| WT1 | Marks epicardial progenitors; regulates EMT | Lineage tracing and conditional KO models |
| TCF21 | Specifies fibroblast lineage; regulates differentiation | KO mice show defective fibroblast development |
| BNC1 | Regulates cell heterogeneity in human epicardium | CRISPR screens in hPSC-derived epicardium |
| TBX18 | Maintains epicardial progenitor state | Overexpression and KO studies |
| SNAI1 | Induces EMT in epicardial cells | Knockdown blocks migration |
| SNAI2 | Promotes mesenchymal transition | Functional studies in chick and mouse |
| GATA4 | Regulates epicardial gene expression | Point mutations linked to CHD |
| GATA6 | Controls epicardial development | Conditional KO models |
| TGFB1 | Induces EMT and fibroblast differentiation | In vitro and in vivo models |
| FGF2 | Promotes EPDC proliferation and migration | Exogenous treatment studies |
| PDGFRA | Mediates EPDC migration | KO and inhibitor studies |
| VIM | Cytoskeletal marker of mesenchymal cells | Immunostaining and lineage tracing |
| COL1A1 | Major ECM component secreted by fibroblasts | Reporter knock-in models |
| COL3A1 | ECM component in cardiac fibrosis | Overexpression and KO models |
| POSTN | Marker of activated fibroblasts | Lineage tracing and KO |
| DDR2 | Collagen receptor regulating fibroblast function | Kinase inhibitor studies |
| HAND2 | Transcription factor in epicardium-derived cells | Conditional KO models |
How Is epicardium-derived cardiac fibroblast cell development Regulated?
The development of epicardium-derived cardiac fibroblasts is regulated by a network of transcription factors (WT1, TCF21, BNC1), signaling pathways (TGF-beta, FGF, PDGF), and epigenetic modifiers. WT1 acts as a master regulator of epicardial EMT and progenitor maintenance. TCF21 is essential for fibroblast lineage specification, and its loss leads to defective fibroblast development. BNC1 controls heterogeneity in human pluripotent stem cell-derived epicardium, influencing differentiation potential. TGF-beta signaling induces EMT and promotes fibroblast maturation, while FGF and PDGF pathways modulate migration and proliferation [2, 4]. Crosstalk with myocardial and endothelial cells further fine-tunes this process [3, 8].
epicardium-derived cardiac fibroblast cell development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| WT1 | Congenital heart defects; fibrosis | Conditional KO mouse; hPSC-derived epicardium |
| TCF21 | Cardiac fibrosis; defective fibroblast development | KO mouse; lineage tracing |
| BNC1 | Epicardial heterogeneity; regeneration | CRISPR KO in hPSC-derived epicardium |
| GATA4 | Ventricular septal defects | Point mutation knock-in mouse |
| COL1A1 | Cardiac fibrosis | Reporter knock-in; overexpression |
Cardiac fibrosis and heart failure
Dysregulated epicardium-derived cardiac fibroblast development contributes to excessive collagen deposition and cardiac fibrosis after myocardial infarction, leading to heart failure. Targeting these fibroblasts or their progenitors is a therapeutic strategy [1, 8].
Congenital heart defects
Mutations in genes regulating epicardial development, such as WT1 and GATA4, are associated with congenital heart defects including ventricular septal defects and coronary anomalies [5, 6].
Impaired cardiac regeneration
In organisms with limited regenerative capacity, insufficient or aberrant epicardium-derived fibroblast development impairs cardiac repair. Enhancing this process may promote regeneration [4, 8].
From epicardium-derived cardiac fibroblast cell development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate epicardial EMT? | Conditional knockout mouse (WT1-Cre; gene X flox) |
| Does a point mutation in gene Y cause congenital heart defects? | Point mutation knock-in mouse |
| Can overexpression of gene Z enhance fibroblast development? | Transgenic overexpression or viral delivery |
| What is the role of gene W in fibroblast maturation? | Tagged knock-in for lineage tracing and proteomics |
| Can CRISPR screen identify novel regulators? | Pooled CRISPR knockout library in hPSC-derived epicardium |
| Does gene V affect ECM secretion? | Reporter knock-in (COL1A1-GFP) and KO |
How to Study the epicardium-derived cardiac fibroblast cell development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing | Cell fate and migration | In vivo mouse models |
| scRNA-seq | Transcriptomic heterogeneity | Human and mouse epicardium |
| CRISPR screen | Gene essentiality | hPSC-derived epicardium |
| Immunofluorescence | Protein localization and markers | Tissue sections and cultured cells |
| Western blot | Protein expression levels | In vitro differentiation |
| ECM secretion assay | Collagen production | Fibroblast maturation |
| Flow cytometry | Cell surface marker expression | Isolation of EPDCs |
Lineage tracing and genetic fate mapping
Lineage tracing using Cre-lox systems (e.g., WT1-Cre, TCF21-Cre) allows researchers to follow the fate of epicardial cells as they differentiate into cardiac fibroblasts in vivo [6, 8].
Transcriptomics and single-cell RNA sequencing
Single-cell RNA sequencing of epicardium-derived cells reveals heterogeneity and identifies novel markers and regulators of fibroblast development.
CRISPR screening and functional genomics
Pooled CRISPR knockout screens in human pluripotent stem cell-derived epicardium can identify genes essential for fibroblast differentiation and maturation.
Imaging and immunohistochemistry
Immunostaining for fibroblast markers (VIM, COL1A1, POSTN) and epicardial markers (WT1, TBX18) visualizes the progression of epicardium-derived cardiac fibroblast development in tissue sections [2, 4].
How CRISPR Can Be Used to Study GO:0060939 epicardium-derived cardiac fibroblast cell development
Knockout
CRISPR knockout of candidate genes such as WT1 or TCF21 in hPSC-derived epicardium or mouse models can reveal their essential roles in epicardium-derived cardiac fibroblast development [6, 7].
Point Mutation
Introducing disease-associated point mutations (e.g., in GATA4) via CRISPR base editing or HDR allows modeling of congenital heart defects and assessing their impact on fibroblast development.
Knock-in
Knock-in of reporter genes (e.g., COL1A1-GFP) or tags enables real-time tracking of fibroblast differentiation and ECM secretion.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of pro-fibrotic factors like TGFB1 can drive enhanced fibroblast development for regenerative studies [2, 8].
How EDITGENE Supports epicardium-derived cardiac fibroblast cell development Research
Researchers studying epicardium-derived cardiac fibroblast cell development-related genes often need to determine whether a candidate gene is causally involved in the process, and CRISPR-based models provide the most direct approach.
Contact EDITGENE today to design your custom CRISPR model for epicardium-derived cardiac fibroblast cell development research.
Frequently Asked Questions About epicardium-derived cardiac fibroblast cell development
What is GO:0060939?
GO:0060939 is the Gene Ontology term for epicardium-derived cardiac fibroblast cell development, the process by which epicardial cells differentiate into mature cardiac fibroblasts that secrete extracellular matrix [1, 2].
What genes are involved in epicardium-derived cardiac fibroblast cell development?
Key genes include WT1, TCF21, BNC1, TBX18, SNAI1, GATA4, and COL1A1, among others [1, 4, 6, 7].
What is the role of WT1 in epicardium-derived cardiac fibroblast development?
WT1 marks epicardial progenitors and regulates epithelial-to-mesenchymal transition, which is essential for fibroblast formation.
How do epicardium-derived cardiac fibroblasts contribute to heart disease?
They are major sources of fibrosis after injury, and their dysregulation leads to excessive collagen deposition and heart failure [1, 8].
What research models are used to study epicardium-derived cardiac fibroblast development?
Lineage tracing mice, conditional knockouts, human pluripotent stem cell-derived epicardium, and CRISPR screens are commonly used [6, 7, 8].
What is the difference between epicardium-derived fibroblasts and other cardiac fibroblasts?
Epicardium-derived fibroblasts originate from the epicardium via EMT, whereas other cardiac fibroblasts may arise from endocardium or circulating progenitors [2, 4].
Can CRISPR be used to study epicardium-derived cardiac fibroblast development?
Yes, CRISPR knockout, knock-in, and activation models enable functional interrogation of genes in this process [7, 8].
What diseases are associated with defects in epicardium-derived cardiac fibroblast development?
Congenital heart defects, cardiac fibrosis, and impaired cardiac regeneration are linked to defects in this process [1, 5, 8].
What is the extracellular matrix role of epicardium-derived cardiac fibroblasts?
They secrete a collagen-rich matrix that provides structural support and signaling cues for heart development and repair [1, 3].
How can I model epicardium-derived cardiac fibroblast development in vitro?
Human pluripotent stem cell-derived epicardium can be differentiated into fibroblasts and used for CRISPR screens and functional assays.
Conclusion
GO:0060939 encompasses the essential developmental program by which epicardial cells give rise to cardiac fibroblasts, a process critical for heart formation and repair. Understanding its regulation and genetic drivers offers insights into congenital heart disease and fibrosis, and provides targets for regenerative therapies [1, 2, 8]. CRISPR-based models and multi-omics approaches are accelerating discoveries in this field, enabling precise interrogation of causal genes and pathways [7, 8].
References
- 1. Fang M et al.. 2016. Epicardium-derived fibroblasts in heart development and disease.. J Mol Cell Cardiol 91:23-7 PMID: 26718723
- 2. Gittenberger-de Groot AC et al.. 2010. Epicardium-derived cells (EPDCs) in development, cardiac disease and repair of ischemia.. J Cell Mol Med 14(5):1056-60 PMID: 20646126
- 3. Nusrat A et al.. 2025. Epicardium-myocardium crosstalk orchestrates heart development.. Front Cell Dev Biol 13:1655878 PMID: 41070347
- 4. Winter EM et al.. 2007. Epicardium-derived cells in cardiogenesis and cardiac regeneration.. Cell Mol Life Sci 64(6):692-703 PMID: 17380310
- 5. Gittenberger-de Groot AC et al.. 2012. The arterial and cardiac epicardium in development, disease and repair.. Differentiation 84(1):41-53 PMID: 22652098
- 6. van den Heuvel-Eibrink MM et al.. 2016. WT1 in Cardiac Development and Disease.. PMID: 27512758
- 7. Gambardella L et al.. 2019. BNC1 regulates cell heterogeneity in human pluripotent stem cell-derived epicardium.. Development 146(24) PMID: 31767620
- 8. Quijada P et al.. 2020. The Role of the Epicardium During Heart Development and Repair.. Circ Res 126(3):377-394 PMID: 31999538
